Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Joint Erosions in Rheumatoid Arthritis
NCT01400516Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in rheumatoid arthritis (RA), sponsored by Brigham and Women's Hospital. Started Aug 2011; status: completed.
02
Drugs
teriparatide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01400516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400516.